MBZUAI Ph.D. student Raza Imam and colleagues presented a new benchmark called MediMeta-C to test the robustness of medical vision-language models (MVLMs) under real-world image corruptions. They found that top-performing MVLMs on clean data often fail under mild corruption, with fundoscopy models particularly vulnerable. To address this, they developed RobustMedCLIP (RMC), a lightweight defense using few-shot LoRA tuning to improve model robustness. Why it matters: This research highlights the critical need for robustness testing in medical AI to ensure reliability in clinical settings, particularly in resource-constrained environments where image quality may be compromised.
The paper introduces MedNNS, a neural network search framework designed for medical imaging, addressing challenges in architecture selection and weight initialization. MedNNS constructs a meta-space encoding datasets and models based on their performance using a Supernetwork-based approach, expanding the model zoo size by 51x. The framework incorporates rank loss and Fréchet Inception Distance (FID) loss to capture inter-model and inter-dataset relationships, improving alignment in the meta-space and outperforming ImageNet pre-trained DL models and SOTA NAS methods.
Researchers at MBZUAI developed a method to measure vital signs using webcams by analyzing color intensity changes in facial blood flow. They built a digital twin system that uses machine learning to combine heart rate, respiratory rate, and blood oxygen level measures. The system displays real-time vital sign information, enabling remote patient triage. Why it matters: This research contributes to the advancement of telemedicine, potentially improving healthcare access in underserved regions and aligning with UN Sustainable Development Goal #3.
MBZUAI researchers are introducing MedNNS, a system to be presented at MICCAI 2025, that recommends the best AI architecture and initialization for medical imaging tasks. MedNNS addresses the challenge of inefficient trial-and-error in building medical imaging AI by reframing model selection as a retrieval problem. The system employs a Once-For-All ResNet-like model and a learned meta-space of 720k model-dataset pairs, using dataset embeddings to predict optimal model performance. Why it matters: By automating model selection, MedNNS promises to significantly reduce the time and resources required to develop effective AI solutions for healthcare, particularly in medical imaging.
MEDAD, a KAUST spin-off, won the 2020 MEED Sustainability Medal for its "Innovative Hybrid Solar Desalination Cycle." The MEDAD hybrid cycle desalinates seawater using solar energy at 60-80 degrees Celsius, combining adsorption with multi-effect desalination. The cycle achieved performance levels of 20% of thermodynamic limits and a water production cost of $0.48/m3. Why it matters: This award recognizes the potential of KAUST-developed technology to address critical water scarcity challenges in the GCC region through sustainable and cost-effective desalination.
Video motion magnification amplifies subtle movements in video footage, making the imperceptible visible across various fields. In healthcare, it allows non-invasive monitoring of vital signs and micro-expressions. In engineering, it helps detect structural vibrations in infrastructure, while also being used in sports science, security, and robotics. Why it matters: The technology's ability to reveal hidden details has the potential to revolutionize diagnostics, monitoring, and decision-making in diverse sectors across the Middle East.
MBZUAI's BiMediX2, a bilingual healthcare multi-modal model, won Meta's Llama Impact Innovation Award for its potential in solving healthcare accessibility challenges across the Middle East and Africa. Built using Llama 3.1, the model understands medical queries in both English and Arabic, interprets medical images, and is integrated as a chatbot on Telegram with speech functionality. The model was also presented at the AI for Sustainable Development Platform Launch Event and integrated into the UNDP for telemedicine. Why it matters: The model's bilingual capabilities and accessibility on low-cost devices and speech-based interaction have potential to improve healthcare access for marginalized populations in the region.
The Russian Immune Diversity Atlas project aims to profile immune cells from people of different ancestries at a multiomics level. The goal is to reconstruct a reference atlas of the healthy immune system and investigate its perturbations in Type II Diabetes (T2D). The project seeks to identify novel mechanisms and genetic/epigenetic markers for early T2D diagnostics, prognosis, and therapy as part of the international Human Cell Atlas. Why it matters: Addressing genetic diversity in biomedical research, particularly in the context of the Human Cell Atlas, is crucial for personalized medicine and ensuring that treatments are effective across diverse populations in the Middle East and globally.